Contemporary Applications of Y90 for the Treatment of Hepatocellular Carcinoma

The potential synergy between transarterial radioembolization and immunotherapy has been recognized, and prospective studies evaluating this combination are needed for patients with Barcelona Clinic Liver Cancer B and C HCC.